. Abnormal TFR phenotype and reduced in vitro suppressive activity of Prdm1 fl/fl FoxP3 Cre TFR. Related to Figures 2 and 3 . A) Flow cytometry of splenic Treg (FoxP3 + CD4 + ) (upper), TFR (CD4 + CD3 + PD-1 + CXCR5 + FoxP3 + ) and non-TFR (CD4 + CD3 + CXCR5 − FoxP3 + ) (middle) from un-immunized FoxP3 Cre (WT) and Prdm1 fl/fl FoxP3 Cre (KO) mice (7-9 wk old). (right), Numbers of Treg, TFR and non-TFR cells (n = 4/ group). Fold changes of KO to WT are indicated. B) Flow cytometry of splenic TFR (CD4 + CD3 + PD-1 + CXCR5 + FoxP3 + ) from 4-5 mo old Prdm1 fl/fl FoxP3 Cre and FoxP3 Cre (WT) mice. C) Total Treg, non-TFR and TFR cell numbers in spleen, peripheral lymph node (pLN) and mLN of 4-5 mo old mice (n = 3/group). D) Flow cytometry of expression of each marker in splenic CD45.2 + cTreg (CD4 + CD3 + CD44 lo CD62L hi FoxP3 + ) or eTreg (CD4 + CD3 + CD44 hi CD62L lo FoxP3 + ) subsets in BM chimera. E) Quantification of Bcl2 MFI in mLN Treg and TFR cells (as in Fig. 2B ). n = 4/group. F) Flow cytometry of FoxP3, CTLA-4 and CD25 expression in splenic TFR and non-TFR cells from (A). G) Intracellular IFN expression by splenic TFR and non-TFR from (A). H) Gating strategy for CD25 lo , CD25 int and CD25 hi populations in PD1 + CXCR5 + FoxP3 + CD4 + TFR cells from WT and Prdm1 fl/fl FoxP3 Cre mice based on CD25 fluorescence intensity. I) Quantification of CCR7 MFI in splenic TFR cells and mLN TFR cells, as in Fig. 2I (n = 4-5/group). J,K) IgG in supernatants of cultures of GL7 -B cells in the presence or absence (-) of TFR, CD25 + or CD25 -TFR cells from FoxP3 Cre (WT) or Prdm1 fl/fl FoxP3 Cre (KO) mice, plus anti-CD3 and anti-IgM. L) Representative plots displaying presort and post-sort purity of TFR from FoxP3 Cre (WT) or Prdm1 fl/fl FoxP3 Cre (KO) mice or TFH from WT mice. In some cases, YFP was replaced with GITR to separate TFR (GITR + ) from TFH (GITR -) cells. A-G and I: data are representative of two independent experiments. NS, no significance, * P < 0.05, ** P < 0.01 and *** P < 0.001 (unpaired two-tailed Student's t-test). Error bars indicate mean ± SEM. Fig. 5A; B) Major pathways in TFR cells regulated by Blimp1 deficiency revealed by GO analysis of 763 genes according to DAVID; C) Major gene families associated with molecular and cellular function revealed by IPA. Figure S5 . Silencing the IL-23R-STAT3 axis restores the Blimp1 deficient TFR phenotype. Related to Figure 6 . A) Flow cytometry of expression of IL-23R, CD25, Helios and Bcl6 in donor Thy1.1 + TFR cells as shown in Fig. 6A . B) Experimental strategy was described as in Fig. 6A , except that a 2 nd IL23R-shRNA was used. Flow cytometry of Thy1.1 + TFR, CD45.1 + TFH and GL7 + B-cells, IL-17A and IFN- production by Thy1.1 + TFR. C) (upper) Flow cytometry of expression of RORt and granzyme B in donor Thy1.1 + TFR cells as in (A); (bottom) Frequency of Thy1.1 + TFR cells expressing RORt and granzyme B. Data are pooled from two experiments (n = 6 per group). D) Histogram overlay of pSTAT3 expression by Treg cells in indicated mouse strains. E) Flow cytometry of TFR (CD4 + TCR + FoxP3 + ICOS + CXCR5 + ) and TFH (CD4 + TCR + FoxP3 -ICOS + CXCR5 + ) from mLN of indicated strains as in Fig. 6D. F) Frequency of TFR and TFH from (E). G) The ratios of TFH : TFR cells and GC B: TFR cells in STAT3 deficiency experiment in Fig. 6D ,E. Results are pooled from two independent experiments (n = 4-9 per group). A,C, D-G: data represent one of two experiments. NS, no significance, * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001 (unpaired two-tailed Student's t-test). Error bars indicate mean ± SEM. Figure S6 . Increasing STAT5 activation in differentiating Blimp1-deficient TFR cells restores lineage stability. Related to Figure 6 . A) Schematic presentation of assay. Prdm1 fl/fl FoxP3 Cre Treg cells were sorted and cultured for 3 d as in Fig. 6A . Cells were then infected with retrovirus expressing the GFP reporter plus constitutively-active STAT5 (STAT5 CA ) or control (Ctrl). On day 4, sorted GFP + Treg along with CD45.1 + naive CD4 + T-cells were transferred into Tcra -/hosts followed by immunization with NP-OVA in CFA on day 11. Splenocytes were analyzed on day 20. B) Flow cytometry of intracellular levels of IL-17A and IFN- by CD45.1 -Bcl6 + TFR. C) Frequency of Bcl6 + IL-17A + and Bcl6 + IFN- + in donor CD45.1 -Treg cells. D) Histogram overlay of expression of pSTAT5 in CD45.2 + FoxP3 + Treg after infection with retrovirus, and expression of CD25 and FoxP3 by CD45.2 + FoxP3 + TFR cells from Tcra -/hosts on day 20 post-transfer and immunization, as described in A. A-D: data represent one of two independent experiments (C: n = 5 per group). * P < 0.05 and ** P < 0.01 (unpaired two-tailed Student's t-test). Error bars indicate mean ± SEM.
